5-hydroxypyrazinoic acid has been researched along with Acute Liver Injury, Drug-Induced in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, S; Dubey, D; Guleria, A; Keshari, AK; Kumar, D; Kumar, U; Prakash, A; Rai, A; Raj, V; Rawat, A; Saha, S; Singh, AK | 1 |
1 other study(ies) available for 5-hydroxypyrazinoic acid and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biomarkers; Biotransformation; Chemical and Drug Induced Liver Injury; Liver; Male; Metabolomics; Microscopy, Electron, Scanning; Multivariate Analysis; Oxidative Stress; Proton Magnetic Resonance Spectroscopy; Pyrazinamide; Rats, Wistar; Risk Assessment; Time Factors; Toxicity Tests | 2018 |